U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2020, it operated 544 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities. The company was founded in 1990 and is based in Houston, Texas.
IPO Year: 1992
Exchange: NYSE
Website: usph.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2026 | $103.00 → $90.00 | Outperform | Barrington Research |
| 3/10/2026 | $102.00 | Buy | Jefferies |
| 9/18/2025 | $110.00 | Overweight | Analyst |
| 12/16/2024 | $100.00 → $115.00 | Neutral → Buy | BofA Securities |
| 12/16/2024 | $113.00 | Mkt Outperform | JMP Securities |
| 10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
| 9/22/2023 | $108.00 | Overweight | JP Morgan |
| 6/30/2023 | $138.00 | Buy | BofA Securities |
| 12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
| 8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Barrington Research reiterated coverage of U.S. Physical Therapy with a rating of Outperform and set a new price target of $90.00 from $103.00 previously
Jefferies resumed coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $102.00
Analyst resumed coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $110.00
BofA Securities upgraded U.S. Physical Therapy from Neutral to Buy and set a new price target of $115.00 from $100.00 previously
JMP Securities initiated coverage of U.S. Physical Therapy with a rating of Mkt Outperform and set a new price target of $113.00
BofA Securities downgraded U.S. Physical Therapy from Buy to Neutral and set a new price target of $90.00 from $114.00 previously
JP Morgan initiated coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $108.00
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00
CJS Securities upgraded U.S. Physical Therapy from Market Perform to Market Outperform and set a new price target of $120.00
Barrington Research reiterated coverage of U.S. Physical Therapy with a rating of Outperform and set a new price target of $139.00 from $130.00 previously
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-Q - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
SCHEDULE 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
DEF 14A - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
SCHEDULE 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
Fastest customizable press release news feed in the world
U.S. Physical Therapy, Inc. (the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the BofA Securities 2026 Healthcare Conference held on May 13, 2026. The presentation included a discussion of the overall operating environment in healthcare, the Company's key initiatives and a broad overview of opportunities. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 784 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), today reported results for the first quarter ended March 31, 2026 ("Q1 2026"). Total net revenue of $198.3 million for Q1 2026, a 7.9% increase over the first quarter ended March 31, 2025 ("Q1 2025"). Net income attributable to USPH shareholders of $5.0 million for Q1 2026, compared to $9.9 million for Q1 2025. Included in pretax income for Q1 2026 was a loss on change in fair value of contingent earn out consideration of $2.0 million versus a gain of $4.8 million in Q1 2025. Under GAAP
PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 7, 2026. Conference Call Date: Thursday, May 7, 2026 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number (800) 445-7795 Primary or (785) 424-1699 Alternate Conference ID:
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced the closing of a $450 million, five-year credit facility that includes a $175 million term loan and a $275 million revolver with a maturity date of April 14, 2031. Based on strong lender support, the credit facility was upsized from its initial $400 million launch amount. This is an increase and extension of the Company's $325 million credit facility which was due to expire on June 17, 2027. Chris Reading, Chairman and CEO, stated, "The credit facility's increased borrowing capacity
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 783 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and r
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $95.0 million for the year ended December 31, 2025 ("2025 Year"), an increase of $13.2 million or 16.2%, from $81.8 million for the year ended December 31, 2024 ("2024 Year"). Net income attributable to USPH shareholders ("USPH Net In
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2025, on Wednesday, February 25, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 26, 2026. Conference Call Date: Thursday, February 26, 2026 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number: (800) 445-7795 Primary or (785) 424-1699 Alternate
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of an industrial injury prevention business for approximately $15.1 million. The business currently generates approximately $7.0 million in annual revenues. USPH acquired a 70% interest and 30% was retained by the current owner. Eric Williams, President and Chief Operating Officer-East, said, "We are extremely pleased to announce this acquisition today which further expands our offerings in industrial injury prevention service lines. The management team is a perfect fit fo
U.S. Physical Therapy, Inc. ("USPH") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced a 10-year strategic alliance between its subsidiary partner, Metro Physical & Aquatic Therapy ("Metro Physical Therapy"), and NYU Langone Health, one of the nation's top-ranked academic medical centers ("NYU Langone"). NYU Langone and Metro Physical Therapy will work together in Long Island and the New York metropolitan area to deliver exceptional physical therapy care to patients throughout the region. This strategic move underscores NYU Langone's commitment to expanding its health care network and to pr
Live finance-specific insights
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), today reported results for the first quarter ended March 31, 2026 ("Q1 2026"). Total net revenue of $198.3 million for Q1 2026, a 7.9% increase over the first quarter ended March 31, 2025 ("Q1 2025"). Net income attributable to USPH shareholders of $5.0 million for Q1 2026, compared to $9.9 million for Q1 2025. Included in pretax income for Q1 2026 was a loss on change in fair value of contingent earn out consideration of $2.0 million versus a gain of $4.8 million in Q1 2025. Under GAAP
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 7, 2026. Conference Call Date: Thursday, May 7, 2026 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number (800) 445-7795 Primary or (785) 424-1699 Alternate Conference ID:
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $95.0 million for the year ended December 31, 2025 ("2025 Year"), an increase of $13.2 million or 16.2%, from $81.8 million for the year ended December 31, 2024 ("2024 Year"). Net income attributable to USPH shareholders ("USPH Net In
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2025, on Wednesday, February 25, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 26, 2026. Conference Call Date: Thursday, February 26, 2026 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number: (800) 445-7795 Primary or (785) 424-1699 Alternate
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of an industrial injury prevention business for approximately $15.1 million. The business currently generates approximately $7.0 million in annual revenues. USPH acquired a 70% interest and 30% was retained by the current owner. Eric Williams, President and Chief Operating Officer-East, said, "We are extremely pleased to announce this acquisition today which further expands our offerings in industrial injury prevention service lines. The management team is a perfect fit fo
U.S. Physical Therapy, Inc. ("USPH") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced a 10-year strategic alliance between its subsidiary partner, Metro Physical & Aquatic Therapy ("Metro Physical Therapy"), and NYU Langone Health, one of the nation's top-ranked academic medical centers ("NYU Langone"). NYU Langone and Metro Physical Therapy will work together in Long Island and the New York metropolitan area to deliver exceptional physical therapy care to patients throughout the region. This strategic move underscores NYU Langone's commitment to expanding its health care network and to pr
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy management services company, which exclusively manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and 66,000 in annual visits. USPH acquired a 50% interest and 50% was retained by the current owners. Graham Reeve, Chief Operating Officer-West, said, "We are excited to welcome our newest partners into the USPH family and expand our service offerings. This team delivers outstanding c
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $23.9 million for the three months ended September 30, 2025 ("2025 Third Quarter"), an increase of $2.8 million, or 13.2%, from $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter") primarily driven by clinic additions. Net income attributable to USPH shareholders ("USPH Net Incom
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and nine months ended September 30, 2025, on Wednesday, November 5, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, November 6, 2025. Conference Call Date: Thursday, November 6, 2025 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID
Reports All-time Record Patient Visits Raises Full Year 2025 Earnings Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $26.9 million for the three months ended June 30, 2025 ("2025 Second Quarter"), an increase of $4.7 million, or 21.4%, from $22.1 million for the three months ended June 30, 2024 ("2024 Second Quarter") primarily driven by higher patient visits.
This live feed shows all institutional transactions in real time.
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
Live Leadership Updates
PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors has appointed Anne Motsenbocker to serve on the Board, effective January 1, 2022. Ms. Motsenbocker served in numerous executive leadership roles in her 36-year career at J.P. Morgan Chase, ultimately serving as the Managing Director and Segment Head of Southwest Middle Market Banking, covering a multi-state region. Previous executive roles at J.P. Morgan Chase included National Head of Multinational Corporations, Chairman of Dallas Market Leadership, President of Dalla